Clinical Evidence: What The Research Shows For UK Patients
Wegovy vs Mounjaro Weight Loss Results: Understanding The Clinical Data
When examining what is the difference between Wegovy and Mounjaro, the most significant distinction lies in their mechanisms of action and clinical trial outcomes. Wegovy (semaglutide) works as a GLP-1 receptor agonist, mimicking a natural fullness hormone that reduces appetite and promotes satiety. In the landmark STEP 1 trial, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo. Mounjaro (tirzepatide) operates as a dual GIP/GLP-1 receptor agonist, potentially offering enhanced glucose control alongside weight management benefits.
The clinical evidence for both treatments demonstrates substantial efficacy when used as part of a comprehensive weight management programme. What is the difference between Wegovy and Mounjaro in terms of trial populations and endpoints means direct comparisons require careful consideration. Both medications are prescription-only medicines that require clinical assessment and ongoing medical supervision. EverydayMeds provides access to both treatments through our GPhC-registered pharmacy (#9012878), allowing your prescriber to determine which option aligns best with your individual health profile and weight management goals.
Wegovy vs Mounjaro Pricing: UK Cost Comparison And Value Analysis
Understanding what is the difference between Wegovy and Mounjaro extends to pricing considerations for UK patients. Wegovy is available at EverydayMeds starting from £79.99 for the 0.25mg starter dose, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. New customers can apply code FIRST40 at checkout to access these prices, while returning customers use code DOSE25. Our bundle options include the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99, providing three months of initial dose escalation.
When considering what is the difference between Wegovy and Mounjaro from a financial perspective, both treatments represent significant investments in long-term health outcomes. EverydayMeds offers convenient bundle packages that ensure treatment continuity without the need for frequent reordering. The Progress Duo (0.5mg & 1mg) costs £189.99, while the Ultimate Stability Trio provides three 2.4mg pens for £649.99. These pricing structures reflect the prescription-only nature of both medications and include comprehensive clinical assessment, prescriber review, and temperature-controlled delivery to maintain medication integrity throughout the supply chain.
Clinical Trial Evidence: STEP Programme Results For Wegovy
The STEP clinical trial programme provides robust evidence for Wegovy's efficacy in weight management. In STEP 1, patients taking Wegovy alongside a reduced-calorie diet and increased physical activity achieved approximately 15% average weight loss at 68 weeks (Wilding et al., NEJM, 2021). STEP 3 demonstrated even greater results with intensive behavioural therapy, showing approximately 16% weight reduction.
What is the difference between Wegovy and Mounjaro becomes clearer when examining long-term sustainability data. STEP 5 revealed that Wegovy maintained approximately clinically studied weight loss at two years, while the SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events. These results represent what patients achieved in controlled clinical settings and individual results may vary based on adherence to dietary and lifestyle modifications alongside medication use.
How Wegovy Works: GLP-1 Mechanism Explained
Understanding what is the difference between Wegovy and Mounjaro requires examining their distinct mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1 produced in the intestines. This hormone regulates blood glucose levels and gastric emptying while sending satiety signals to the brain's appetite control centres. When administered as a once-weekly injection via the FlexTouch pen device, Wegovy may help reduce appetite and promote feelings of fullness after consuming smaller portions. The medication works synergistically with lifestyle modifications including a reduced-calorie diet and increased physical activity. Clinical studies suggest that Wegovy may also influence food cravings and reward pathways in the brain, potentially making it easier for patients to adhere to healthier eating patterns throughout their weight management journey.
EverydayMeds Ordering Process: From Assessment To Delivery
Accessing Wegovy through EverydayMeds follows a streamlined yet thorough clinical pathway designed to ensure patient safety and treatment appropriateness. The process begins with a comprehensive 3-minute online clinical assessment that evaluates your medical history, current medications, and weight management goals to determine suitability for prescription-only medicines. Following submission, our qualified prescribers conduct a detailed review, typically completed within three working days, though express 24-hour review services are available for urgent cases. Once approved, your Wegovy prescription is dispensed from our GPhC-registered pharmacy (#9012878) and dispatched via next-day delivery using specialist cold-chain packaging to maintain the medication's temperature requirements. This end-to-end process ensures that what is the difference between Wegovy and Mounjaro can be properly evaluated by healthcare professionals who understand your individual clinical needs. Each delivery includes comprehensive injection guidance, dose escalation schedules, and ongoing support resources to maximise treatment success and safety throughout your weight management programme.
Storage Requirements: Wegovy vs Mounjaro Practical Considerations
What is the difference between Wegovy and Mounjaro extends to practical storage requirements that can impact treatment convenience and medication stability. Wegovy requires refrigeration at 2-8°C before first use but offers superior room temperature stability, remaining effective for up to 6 weeks when stored below 30°C after removal from refrigeration. This storage advantage makes Wegovy particularly suitable for patients who travel frequently or have limited refrigeration access during portions of their treatment cycle. In contrast, Mounjaro maintains stability for only 21 days at room temperature, requiring more stringent cold storage management. Both medications utilise pre-filled pen injection systems, with Wegovy's FlexTouch device providing clear dose escalation from 0.25mg starter dose through to 2.4mg maintenance therapy. The dose escalation protocol is mandatory for both treatments and cannot be accelerated, ensuring gradual adaptation to the medication's effects while minimising potential gastrointestinal side effects that may occur with rapid dosing increases.
UK Weight Management Context: NICE Guidelines And Treatment Access
When evaluating what is the difference between Wegovy and Mounjaro within the UK healthcare context, both treatments fall under NICE guidance for weight management in adults with BMI ≥30 or BMI ≥27 with weight-related comorbidities. Wegovy received NICE approval through TA875, which recommends its use alongside specialist weight management support for eligible patients. The medication is also licensed for adolescents aged 12 years and over with body weight exceeding 60kg and BMI corresponding to obesity in adults. This broader licensing reflects the growing recognition of obesity as a chronic medical condition requiring pharmaceutical intervention alongside lifestyle modifications.
EverydayMeds operates within this regulatory framework, ensuring that what is the difference between Wegovy and Mounjaro is properly evaluated by qualified prescribers who understand both treatments' clinical profiles. Both medications require ongoing medical supervision and are subject to MHRA additional monitoring, indicated by the black triangle (▼) symbol. Our clinical team stays current with evolving guidance and safety data, providing patients with evidence-based treatment decisions. The prescription-only classification of both medications reflects their potent pharmacological effects and the need for professional oversight throughout treatment duration, particularly given the weight regain observed when treatment is discontinued without continued lifestyle modifications.
Making Your Treatment Decision: Expert Guidance Available
Determining what is the difference between Wegovy and Mounjaro for your specific situation requires individualised clinical assessment that considers your medical history, treatment goals, and lifestyle factors. Both medications are available through EverydayMeds, and our prescribers can help evaluate which option aligns best with your weight management objectives. Factors such as storage convenience, injection frequency, and clinical efficacy profiles all contribute to treatment selection decisions. New customers can begin their assessment today using discount code FIRST40 at checkout, while returning customers benefit from code DOSE25 for continued treatment access. Visit https://everydaymeds.co.uk/collections/wegovy to start your clinical assessment and take the first step towards evidence-based weight management with professional medical support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
